COVID-19 ACTIV-4 ACUTE A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 (ACTIV4A)
Source: NCBI BioProject (ID PRJNA781336)
Source: NCBI BioProject (ID PRJNA781336)
0 0
Project name: COVID-19 ACTIV-4 ACUTE A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 (ACTIV4A)
Description: This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients.
Data type: Phenotype or Genotype
Sample scope: Multiisolate
Relevance: Medical
Organization: UNIVERSITY OF PITTSBURGH AT PITTSBURGH